Literature DB >> 2563989

Sulfasalazine therapy in inflammatory bowel disease.

K M Das1.   

Abstract

Sulfasalazine currently is the most commonly prescribed medication for inflammatory bowel disease. Insights into the pharmacokinetics, their side effects and mechanism and their possible mode of action has led to rational basis for its clinical use and the development of new related agents. This review summarizes these aspects and discusses the future role of sulfasalazine in the face of new oral preparations.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2563989

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN： 0889-8553            Impact factor:   3.806


  11 in total

1.  Current medical therapy of inflammatory bowel disease.

Authors:  Kiron M Das; Sherif A Farag
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 2.  Hypersensitivity to 5-ASA suppositories.

Authors:  M L Borum; A Ginsberg
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

3.  Azathioprine reduces extravasation and neutrophil trafficking in immune complex-mediated inflammation in the rat colon.

Authors:  S N Murthy; T Anania; H R Clearfield
Journal:  Agents Actions       Date:  1991-09

Review 4.  A practical guide to the management of distal ulcerative colitis.

Authors:  S Ardizzone; G Bianchi Porro
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

5.  Histopathological comparison of topical therapy modalities for acute radiation proctitis in an experimental rat model.

Authors:  Cagatay Korkut; Oktar Asoglu; Murat Aksoy; Yersu Kapran; Hatice Bilge; Nese Kiremit-Korkut; Mesut Parlak
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 6.  Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel disease.

Authors:  O H Nielsen; I Ahnfelt-Rønne
Journal:  Klin Wochenschr       Date:  1991-12-15

Review 7.  Comparative tolerability of therapies for ulcerative colitis.

Authors:  Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

8.  Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.

Authors:  L G Quallich; J Greenson; H M Haftel; R J Fontana
Journal:  BMC Gastroenterol       Date:  2001-08-29       Impact factor: 3.067

9.  Rheumatoid arthritis is an autoimmune disease caused by periodontal pathogens.

Authors:  Mesut Ogrendik
Journal:  Int J Gen Med       Date:  2013-05-24

10.  Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques.

Authors:  Ivona Pandrea; Cuiling Xu; Jennifer L Stock; Daniel N Frank; Dongzhu Ma; Benjamin B Policicchio; Tianyu He; Jan Kristoff; Elaine Cornell; George S Haret-Richter; Anita Trichel; Ruy M Ribeiro; Russell Tracy; Cara Wilson; Alan L Landay; Cristian Apetrei
Journal:  PLoS Pathog       Date:  2016-01-14       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.